 |
|
Associations Between the Age at Diagnosis and Location of Colorectal Cancer and the Use of Alcohol and Tobacco
Implications for Screening
Anna L. Zisman, MD;
Angel Nickolov, MA;
Randall E. Brand, MD;
Addi Gorchow, MBA;
Hemant K. Roy, MD
Arch Intern Med. 2006;166:629-634.
Background Individualizing recommendations for colorectal cancer (CRC) screening intervals and modalities requires accurate risk assessment. Although hereditary predisposition is commonly used, the effect of exogenous risk factors has remained largely unexplored. To address this, we analyzed the age at presentation and location of CRC in relation to alcohol and tobacco use.
Methods We queried the IMPAC Medical Registry Services Cancer Information Resource File for CRCs diagnosed between June 1, 1993, and December 31, 2003. Subjects were classified as current, past, or never users of alcohol and tobacco. A logistic regression model for location of CRC and a linear regression model for age at diagnosis were constructed using these explanatory variables along with gender, race, and insurance status.
Results Our data set consisted of 161 172 patients with CRC. Current drinking, smoking, and smoking plus drinking were associated with younger ages at onset of CRC (adjusted age difference, 5.2, 5.2, and 7.8 years, respectively; P<.001 for all). A distal location of CRC was more likely to occur in current drinkers (odds ratio, 1.192; 95% confidence interval, 1.15-1.23) and smokers (odds ratio, 1.164; 95% confidence interval, 1.12-1.21). Colorectal cancer in men tended to occur earlier (adjusted age difference, 1.9 years; P<.001) and have a distal predominance (odds ratio, 1.42; P<.001) compared with women. The smoking but not the drinking effect size was greater in women than in men (adjusted age difference, 2.6 years; P<.001).
Conclusions Alcohol use, tobacco use, and male gender were associated with earlier onset and a distal location of CRC. If confirmed, these factors should guide recommendations regarding initiation of CRC screening and, possibly, choice of techniques.
Author Affiliations: Department of Internal Medicine (Drs Zisman, Brand, and Roy and Ms Gorchow) and Center on Outcomes Research and Education (Mr Nickolov), Evanston–Northwestern Healthcare, Feinberg School of Medicine, Northwestern University, Evanston, Ill.
RELATED LETTERS
N-acetylcysteine for Contrast Nephropathy: More Clinical Science Is Required
Michael Eddleston, Jane Goddard, and Nick Bateman
Arch Intern Med. 2006;166(15):1668-1669.
EXTRACT
| FULL TEXT
N-acetylcysteine for Contrast Nephropathy: More Clinical Science Is Required—Reply
Sean M. Bagshaw, Finlay A. McAlister, Braden J. Manns, and William A. Ghali
Arch Intern Med. 2006;166(15):1669.
EXTRACT
| FULL TEXT
Smoking and Risk for Colorectal Cancer
Joseph Carl Anderson and Catherine Messina
Arch Intern Med. 2006;166(15):1669-1670.
EXTRACT
| FULL TEXT
The Age-at-Diagnosis Fallacy
John A. Baron
Arch Intern Med. 2006;166(15):1670.
EXTRACT
| FULL TEXT
Smoking and Age at Cancer Diagnosis
Arthur Michael Michalek and K. Michael Cummings
Arch Intern Med. 2006;166(15):1670-1671.
EXTRACT
| FULL TEXT
Smoking and Age at Cancer Diagnosis—Reply
Anna L. Zisman, Randall E. Brand, and Hemant K. Roy
Arch Intern Med. 2006;166(15):1671.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Cigarette Smoking and Irinotecan Treatment: Pharmacokinetic Interaction and Effects on Neutropenia
van der Bol et al.
JCO 2007;25:2719-2726.
ABSTRACT
| FULL TEXT
A NAD(P)H:Quinone Oxidoreductase 1 Polymorphism Is a Risk Factor for Human Colon Cancer
Begleiter et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:2422-2426.
ABSTRACT
| FULL TEXT
The Age-at-Diagnosis Fallacy.
Baron
Arch Intern Med 2006;166:1670-1670.
FULL TEXT
Smoking and Risk for Colorectal Cancer.
Anderson and Messina
Arch Intern Med 2006;166:1669-1670.
FULL TEXT
Smoking and Age at Cancer Diagnosis.
Michalek and Cummings
Arch Intern Med 2006;166:1670-1671.
FULL TEXT
In brief
BMJ 2006;332:810-810.
FULL TEXT
|
